← Browse by Condition
Medical Condition

tumor thrombosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06389422 Phase 2
Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Enrollment
30 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →